Exonate's Grant

Exonate raised a round of funding on February 06, 2017. Investors include Wellcome Trust.

Exonate is a biopharmaceutical company focussed on the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. Alterna…

Articles about Exonate's Grant: